Article | Published:

Dendritic cells and the control of immunity

Naturevolume 392pages245252 (1998) | Download Citation



B and T lymphocytes are the mediators of immunity, but their function is under the control of dendritic cells. Dendritic cells in the periphery capture and process antigens, express lymphocyte co-stimulatory molecules, migrate to lymphoid organs and secrete cytokines to initiate immune responses. They not only activate lymphocytes, they also tolerize T cells to antigens that are innate to the body (self-antigens), thereby minimizing autoimmune reactions. Once a neglected cell type, dendritic cells can now be readily obtained in sufficient quantities to allow molecular and cell biological analysis. With knowledge comes the realization that these cells are a powerful tool for manipulating the immune system.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Steinman, R. M. in Fundamental Immunology(ed. Paul, W. E.) 4th edn (Lippincott-Raven, Philadelphia, in the press).

  2. 2

    Inaba, al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702 (1992).

  3. 3

    Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258–261 (1992).

  4. 4

    Szabolcs, P., Moore, M. A. S. & Young, J. W. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J. Immunol. 154, 5851–5861 (1995).

  5. 5

    Romani, al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83–93 (1994).

  6. 6

    Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109–1118 (1994).

  7. 7

    Sallusto, F. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen to the MHC class II compartment. Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400 (1995).

  8. 8

    Romani, al. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J. Immunol. Meth. 196, 137–151 (1996).

  9. 9

    Reddy, A., Sapp, M., Feldman, M., Subklewe, M. & Bhardwaj, N. Amonocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90, 3640–3646 (1997).

  10. 10

    Maraskovsky, al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 and ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953–1962 (1996).

  11. 11

    Adema, G. al. Adendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387, 713–717 (1997).

  12. 12

    Mueller, C. G. al. Polymerase chain reaction selects a novel disintegrin-proteinase from CD40-activated germinal center dendritic cells. J. Exp. Med. 186, 655–663 (1997).

  13. 13

    Greaves, D. al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 186, 837–844 (1997).

  14. 14

    Winzler, al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317–328 (1997).

  15. 15

    Bhardwaj, N., Young, J. W., Nisanian, A. J., Baggers, J. & Steinman, R. M. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178, 633–642 (1993).

  16. 16

    Inaba, K., Inaba, M., Naito, M. & Steinman, R. M. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J.Exp. Med. 178, 479–488 (1993).

  17. 17

    Moll, H., Fuchs, H., Blank, C. & Rollinghoff, M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23, 1595–1601 (1993).

  18. 18

    Zitvogel, al. Therapy of murine tumors with tumor peptide pulsed dendritic cells: Dependence on T-cells, B7 costimulation, and Th1-associated cytokines. J. Exp. Med. 183, 87–97 (1996).

  19. 19

    Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M. P. Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J. Exp. Med. 183, 317–322 (1996).

  20. 20

    Mayordomo, J. al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1, 1297–1302 (1995).

  21. 21

    Hsu, F. al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52–58 (1996).

  22. 22

    Ingulli, E., Mondino, A., Khoruts, A. & Jenkins, M. K. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J. Exp. Med. 185, 2133–2141 (1997).

  23. 23

    Luther, S. A., Gulbranson-Judge, A., Acha-Orbea, H. & Maclennan, I. C. M. Viral superantigen drives extrafollicular and follicular B differentiation leading to virus-specific antibody production. J. Exp. Med. 185, 551–562 (1997).

  24. 24

    Kudo, S., Matsuno, K., Ezaki, T. & Ogawa, M. Anovel migration pathway for rat dendritic cells from the blood: Hepatic sinusoids-lymph translocation. J. Exp. Med. 185, 777–784 (1997).

  25. 25

    Inaba, al. High levels of a major histocompatibility complex II–self peptide complex on dendritic cells from lymph node. J. Exp. Med. 186, 665–672 (1997).

  26. 26

    Cella, al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747–752 (1996).

  27. 27

    Koch, al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741–747 (1996).

  28. 28

    Reis e Sousa, al. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. Med. 186, 1819–1829 (1997).

  29. 29

    Caux, al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841–1847 (1994).

  30. 30

    Inaba, al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849–1860 (1994).

  31. 31

    Bhardwaj, al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic resonses from human CD8+ T cells. J. Clin. Invest. 94, 797–807 (1994).

  32. 32

    Bender, A., Bui, L. K., Feldman, M. A. V., Larsson, M. & Bhardwaj, N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 182, 1663–1671 (1995).

  33. 33

    Caux, al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263–1272 (1994).

  34. 34

    Wong, B. al. TRANCE, a new TNF family member predominantly expressed in T cells, is a dendritic cell specific survival factor. J. Exp. Med. 186, 2075–2080 (1997).

  35. 35

    Anderson, D. al. Ahomologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175–179 (1997).

  36. 36

    Lukas, al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106, 1293–1299 (1996).

  37. 37

    Reis e Sousa, C., Stahl, P. D. & Austyn, J. M. Phagocytosis of antigens by Langerhans cells in vitro. J.Exp. Med. 178, 509–519 (1993).

  38. 38

    Svensson, M., Stockinger, B. & Wick, M. J. Bone marrow-derived dendritic cells can process bacteria for MHC-1 and MHC-II presentation to T cells. J. Immunol. 158, 4229–4236 (1997).

  39. 39

    Jiang, al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151–155 (1995).

  40. 40

    Nijman, H. al. Antigen capture and MHC class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182, 163–174 (1995).

  41. 41

    Pierre, al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787–792 (1997).

  42. 42

    Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782–787 (1997).

  43. 43

    Albert, M. L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class-I restricted CTLs. Nature 392, 86–89 (1998).

  44. 44

    Buelens, al. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by IL-10. Eur. J. Immunol. 27, 1848–1852 (1997).

  45. 45

    Sallusto, F., Nicolo, C., De Maria, R., Corinti, S. & Testi, R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Exp. Med. 184, 2411–2416 (1996).

  46. 46

    Granelli-Piperno, A., Pope, M., Inaba, K. & Steinman, R. M. Coexpression of REL and SP1 transcription factors in HIV-1 induced, dendritic cell-T cell syncytia. Proc. Natl Acad. Sci. USA 92, 1094–10948 (1995).

  47. 47

    Kitajima, T., Arizumi, K., Bergstresser, P. R. & Takashima, A. Anovel mechanism of glucocorticoid-induced immune suppression: The inhibition of T cell-mediated terminal maturation of a murine dendritic cell line. J. Clin. Invest. 98, 142–147 (1996).

  48. 48

    Brocker, T. Survival of mature CD4 T lymphocytes is dependent on MHC class II expressing dendritic cells. J. Exp. Med. 186, 1223–1232 (1997).

  49. 49

    O'Doherty, al. Human blood contains two subsets of dendritic cells, one immunologically mature, and the other immature. Immunology 82, 487–493 (1994).

  50. 50

    Brown, K. al. Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules. Clin. Exp. Immunol. 107, 601–607 (1997).

  51. 51

    Matsuno, K., Ezaki, T., Kudo, S. & Uehara, Y. Alife stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis and translocation from the liver to hepatic lymph. J. Exp. Med. 183, 1865–1878 (1996).

  52. 52

    McWilliam, A. al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184, 2429–2432 (1996).

  53. 53

    Roake, J. al. Dendritic cell loss from non-lymphoid tissues following systemic administration of lipopolysaccharide, tumour necrosis factor, and interleukin-1. J. Exp. Med. 181, 2237–2248 (1995).

  54. 54

    MacPherson, G. G., Jenkins, C. D., Stein, M. J. & Edwards, C. Endotoxin-mediated dendritic cell release from the intestine: Characterization of released dendritic cells and TNF dependence. J.Immunol. 154, 1317–1322 (1995).

  55. 55

    De Smedt, al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184, 1413–1424 (1996).

  56. 56

    Hosoi, al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363, 159–162 (1993).

  57. 57

    Sozzani, al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292–3295 (1995).

  58. 58

    Young, J. W., Szabolcs, P. & Moore, M. A. S. Identification of dendritic cell colony-forming units among normal CD4+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J. Exp. Med. 182, 1111–1120 (1995).

  59. 59

    Saunders, al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 184, 2185–2196 (1996).

  60. 60

    Flores-Romo, al. CD40 ligation on human CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185, 341–349 (1997).

  61. 61

    Caux, al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNFα. J. Exp. Med. 184, 695–706 (1996).

  62. 62

    Strunk, D., Egger, C., Leitner, G., Hanau, D. & Stingl, G. Askin homing molecule defines the Langerhans cells progenitor in human peripheral blood. J. Exp. Med. 185, 1131–1136 (1997).

  63. 63

    Caux, al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα: II Functional analysis. Blood 90, 1458–1470 (1997).

  64. 64

    Szabolcs, al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-CFU intermediate. Blood 87, 4520–4530 (1996).

  65. 65

    Borkowski, T. A., Letterio, J. J., Farr, A. G. & Udey, M. C. Arole for endogenous transforming growth factor β1 in Langerhans cell biology: The skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417–2422 (1996).

  66. 66

    Suss, G. & Shortman, K. Asubclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand induced apoptosis. J. Exp. Med. 183, 1789–1796 (1996).

  67. 67

    Ardavin, C., Wu, L., Li, C. & Shortman, K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362, 761–763 (1993).

  68. 68

    Grouard, al. The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand. J. Exp. Med. 185, 1101–1111 (1997).

  69. 69

    Lieberman, P. al. Langerhans cell [eosinophilic] granulomatosis. A clinicopathologic study encompassing 50 years. Am. J. Surg. Pathol. 20, 519–552 (1996).

  70. 70

    Dubois, al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185, 941–951 (1997).

  71. 71

    Fayette, al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185, 1909–1918 (1997).

  72. 72

    Frankel, S. al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272, 115–117 (1996).

  73. 73

    Frankel, S. al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am. J. Pathol. 151, 89–96 (1997).

  74. 74

    Kelsall, B. L. & Strober, W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's Patch. J. Exp. Med. 183, 237–247 (1996).

  75. 75

    Matsumoto, al. Distinct roles of lymphotoxin-α and type 1 TNF receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J. Exp. Med. 186, 1997–2004 (1997).

  76. 76

    Liu, Y.-J., Grouard, G., de Bouteiller, O. & Banchereau, J. Follicular dendritic cells and germinal centers. Int. Rev. Cytology 166, 139–179 (1996).

  77. 77

    Liu, al. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185, 165–170 (1997).

  78. 78

    Grouard, G., Durand, I., Filgueira, L., Banchereau, J. & Liu, Y.-J. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384, 364–367 (1996).

  79. 79

    Brocker, T. & Karjalainen, K. Targeted expression of MHC class II molecules demonstrates that dendritic cells can induce negative but no positive selection of thymocytes in vivo. J. Exp. Med. 185, 541–550 (1997).

  80. 80

    Laufer, T. M., DeKoning, J., Markowitz, J. S., Lo, D. & Glimcher, L. H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383, 81–85 (1996).

  81. 81

    Zal, T., Volkmann, A. & Stockinger, B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180, 2089–2099 (1994).

  82. 82

    Kurts, al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923–930 (1996).

  83. 83

    Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P. & Heath, W. R. Class I-restricted cross-presentation of exogenous self antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186, 239–245 (1997).

  84. 84

    Forster, I. & Lieberam, I. Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur. J. Immunol. 26, 3194–3202 (1996).

  85. 85

    Soderberg-Naucler, C., Fish, K. N. & Nelson, J. A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119–126 (1997).

  86. 86

    Rettig, M. al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276, 1851–1854 (1997).

  87. 87

    Cameron, P. al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257, 383–387 (1992).

  88. 88

    Weissman, D., Barker, T. D. & Fauci, A. S. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J. Exp. Med. 183, 687–692 (1996).

  89. 89

    Pinchuk, L. M., Polacino, P. S., Agy, M. B., Klaus, S. J. & Clark, E. A. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1, 317–325 (1994).

  90. 90

    Pope, al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389–398 (1994).

  91. 91

    Grosjean, al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 186, 801–812 (1997).

  92. 92

    Schnorr, al. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl Acad. Sci. USA 94, 5326–531 (1997).

  93. 93

    Fugier-Vivier, al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186, 813–823 (1997).

  94. 94

    Pope, M., Elmore, D., Ho, D. & Marx, P. Dendritic cell–T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV. AIDS Res. Hum. Retro. 13, 819–827 (1997).

  95. 95

    Chaux, P., Moutet, M., Faivre, J., Martin, F. & Martin, M. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 constimulatory molecules of the T-cell activation. Lab. Invest. 74, 975–983 (1996).

  96. 96

    Specht, J. al. Dendritic cells retrovirally transduced with a model tumor antigen gene are therapeutically effective against established pulmonary metastates. J. Exp. Med. 186, 1213–1221 (1997).

  97. 97

    Song, al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247–1256 (1997).

  98. 98

    Schuler, G. & Steinman, R. M. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183–1187 (1997).

  99. 99

    Josien, R., Heslan, M., Soulillou, J.-P. & Cuturi, M.-C. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism. J. Exp. Med. 186, 467–472 (1997).

  100. 100

    Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K. & Falo, L. D. J DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2, 1122–1128 (1996).

  101. 101

    Casares, S., Inaba, K., Brumeanu, T., Steinman, R. M. & Bona, C. A. Antigen presentation by dendritic cells following immunization with DNA encoding a class II-restricted viral epitope. J. Exp. Med. 186, 1481–1486 (1997).

  102. 102

    Colonna, al. Acommon inhibitory receptor for MHC class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809–1818 (1997).

  103. 103

    Vicari, A. al. TECK: A novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7, 291–302 (1997).

Download references


We dedicate this review to the memory of J. Chiller. J.B. acknowledges the members of the Schering Plough Laboratory for Immunological Research, Dardilly, and particularly F. Brière, C. Caux, S. Lebecque, Y.-J. Liu, M. Vatan, A.Waitz, and R.S. acknowledges the long-standing contributions of N.Bhardwaj, A. Granelli-Piperno, K. Inaba, I. Mellman, C. Moberg, M. Nussenzweig, M. Pack, M. Pope, N. Romani, G. Schuler, J.Young and the support of the NIAID. Because of space limitations, the reference list has been restricted to a select sample from the past five years. A more complete list is available from the authors. We thank our many colleagues for their critical comments on this review.

Author information


  1. Baylor Institute for Immunology, Research, Baylor Research Institute, 3409 Worth Street, Dallas, 75246, Texas, USA

    • Jacques Banchereau
    •  & Ralph M. Steinman
  2. Laboratory of Cellular Physiology and Immunology, Rockefeller University, 1230 New York Avenue, New York, 10021-6399, New York, USA

    • Jacques Banchereau
    •  & Ralph M. Steinman


  1. Search for Jacques Banchereau in:

  2. Search for Ralph M. Steinman in:

About this article

Publication history

Issue Date


Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.